Search research articles
Contact Us
Filters
Showing results (71-80 of 335) with videos related to
Page
of 34
Sort By:
FEBS Open Bio
|
May 18, 2021
The structure of gangliosides hides a code for determining neuronal functions
Giulia Lunghi, Maria Fazzari, Erika Di Biase, et al.
American Heart Journal
|
August 23, 2006
The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients
David Charytan, Laura Mauri, Anupam Agarwal, et al.
JACC. Cardiovascular Interventions
|
February 24, 2015
Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy
Donald E Cutlip, Dean J Kereiakes, Laura Mauri, et al.
Glycoconjugate Journal
|
November 17, 2020
Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells
Giulia Lunghi, Maria Fazzari, Erika Di Biase, et al.
Glycoconjugate Journal
|
January 22, 2022
Novel insights on GM1 and Parkinson's disease: A critical review
Maria Fazzari, Erika Di Biase, Giulia Lunghi, et al.
American Heart Journal
|
February 3, 2015
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents
Pallav Garg, Benjamin Z Galper, David J Cohen, et al.
International Journal of Molecular Sciences
|
February 5, 2020
GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration
Elena Chiricozzi, Giulia Lunghi, Erika Di Biase, et al.
Glycoconjugate Journal
|
January 11, 2025
Effect of CFTR modulators Elexacaftor/Tezacaftor/Ivacaftor on lipid metabolism in human bronchial epithelial cells
Dorina Dobi, Nicoletta Loberto, Laura Mauri, et al.
JACC. Cardiovascular Interventions
|
April 23, 2013
Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents
David E Kandzari, Martin B Leon, Ian Meredith, et al.
Circulation
|
November 4, 2005
Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials
Laura Mauri, E John Orav, Susana C Candia, et al.
Page
of 34
Search research articles
Search
Showing results (71-80 of 335) with videos related to
Sort By:
Page
of 34
FEBS Open Bio
|
May 18, 2021
The structure of gangliosides hides a code for determining neuronal functions
Giulia Lunghi, Maria Fazzari, Erika Di Biase, et al.
American Heart Journal
|
August 23, 2006
The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients
David Charytan, Laura Mauri, Anupam Agarwal, et al.
JACC. Cardiovascular Interventions
|
February 24, 2015
Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy
Donald E Cutlip, Dean J Kereiakes, Laura Mauri, et al.
Glycoconjugate Journal
|
November 17, 2020
Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells
Giulia Lunghi, Maria Fazzari, Erika Di Biase, et al.
Glycoconjugate Journal
|
January 22, 2022
Novel insights on GM1 and Parkinson's disease: A critical review
Maria Fazzari, Erika Di Biase, Giulia Lunghi, et al.
American Heart Journal
|
February 3, 2015
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents
Pallav Garg, Benjamin Z Galper, David J Cohen, et al.
International Journal of Molecular Sciences
|
February 5, 2020
GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration
Elena Chiricozzi, Giulia Lunghi, Erika Di Biase, et al.
Glycoconjugate Journal
|
January 11, 2025
Effect of CFTR modulators Elexacaftor/Tezacaftor/Ivacaftor on lipid metabolism in human bronchial epithelial cells
Dorina Dobi, Nicoletta Loberto, Laura Mauri, et al.
JACC. Cardiovascular Interventions
|
April 23, 2013
Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents
David E Kandzari, Martin B Leon, Ian Meredith, et al.
Circulation
|
November 4, 2005
Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials
Laura Mauri, E John Orav, Susana C Candia, et al.
Page
of 34